Is your website vulnerable to XSS?

Over 70% are. Detect & Fix Your Vulnerabilities With Acunetix

  • Scan for SQL injection, XSS, and
    4500+ additional vulnerabilities
  • Detect over 1200 WordPress core, theme,
    and plugin vulnerabilties
  • Fast & Scalable – crawl hundreds of thousands
    of pages without interruptions

GET A FREE 14-DAY TRIAL!

We respect your privacy

Trusted by 1000+ Companies

Test for Cross-Site Scripting (XSS) and other vulnerabilities with Acunetix

Multi-threaded, lightning fast crawler and scanner that can crawl hundreds of thousands of pages without interruptions.

  • Detects over 4500 web application vulnerabilities including XSS.
  • Scans open-source software and custom-built applications.
  • Detects critical vulnerabilities with 100% accuracy.
Web vulnerability scanner

Highest Detection Rate – Highest SQL Injection and XSS Detection Rate

Acunetix are the pioneers in automated web application security testing using innovative technologies

  • DeepScan Technology – crawls all websites including Single Page Applications (SPAs) developed using HTML5, JavaScript and RESTful APIs.
  • Industry’s most advanced SQLi and Cross-site Scripting testing – includes advanced detection of DOM-based XSS.
  • Easy to use Login Sequence Recorder – automatically scans complex password protected areas.
Vulnerability Scanner

Lowest False Positives – Interactive Application Security Testing (IAST) with AcuSensor

Combines black-box and white-box testing to enhance a scan’s detection rate, while enabling easier remediation

  • AcuSensor Technology – enhances a regular dynamic scan through the deployment of sensors inside the source code, relaying feedback upon source code execution.
  • Highest detection of WordPress vulnerabilities – scans WordPress installations for over 1200 known vulnerabilities in WordPress’ core, themes and plugins.
  • Built-in Vulnerability Management – easily review vulnerability data and generate multiple technical and compliance reports.
Low false positives

© Acunetix, 2018